P
Paulus Kirchhof
Researcher at University of Birmingham
Publications - 659
Citations - 119822
Paulus Kirchhof is an academic researcher from University of Birmingham. The author has contributed to research in topics: Atrial fibrillation & Medicine. The author has an hindex of 100, co-authored 558 publications receiving 106459 citations. Previous affiliations of Paulus Kirchhof include United States Department of Veterans Affairs & Georgetown University Medical Center.
Papers
More filters
Journal ArticleDOI
Detection of unknown atrial fibrillation by prolonged ECG monitoring in an all-comer patient cohort and association with clinical and Holter variables
Muhammad Jawad-Ul-Qamar,Winnie Chua,Yanish Purmah,Muhammad Nawaz,Chetan Varma,Russell C. Davis,Abdul Maher,Larissa Fabritz,Paulus Kirchhof +8 more
TL;DR: Open multispeciality access to prolonged ECG monitoring, for example, as part of integrated, cross-sector AF care, can accelerate diagnosis of AF and increase adequate use of oral anticoagulation, especially in older and symptomatic patients with comorbidities.
Journal ArticleDOI
Perceived vs. objective frailty in patients with atrial fibrillation and impact on anticoagulant dosing: an ETNA-AF-Europe sub-analysis
Igor Diemberger,Stefano Fumagalli,Annamaria Mazzone,Ameet Bakhai,Paul-Egbert Reimitz,Ladislav Pecen,Marius Constantin Manu,José Antonio Gordillo de Souza,Paulus Kirchhof,Raffaele De Caterina +9 more
TL;DR: Physicians’ perception of frailty in AF patients is variable, mainly driven by age, sex, and weight, and quite different compared with the results of an objective frailty assessment, Whatever the approach, frailty appears to be associated with non-recommended anticoagulant dosages.
Journal ArticleDOI
Almanac 2015: atrial fibrillation research in Heart
TL;DR: An overview of articles on atrial fibrillation published in Heart in 2014–2015 is provided, highlighting new developments, emerging concepts and novel approaches to treatment.
Journal ArticleDOI
Drugs that interact with cardiac electro-mechanics: Old and new targets for treatment
TL;DR: Several recently identified regulatory mechanisms may provide novel antiarrhythmic targets associated with the "intermediate" response of the myocardium to stretch, which is a continuum from short-term to long-term effects.
Journal ArticleDOI
Cytokine-Mediated Alterations of Human Cardiac Fibroblast’s Secretome
Hanna Bräuninger,Tilo Thottakara,Jacob Schön,Svenja Voss,Vishnu M. Dhople,Svenja Warnke,Katharina Scherschel,Benedikt Schrage,Paulus Kirchhof,Stefan Blankenberg,Uwe Völker,Dirk Westermann,Elke Hammer,Diana Lindner +13 more
TL;DR: In this paper, the secretome and corresponding transcriptome of human cardiac fibroblasts from patients with dilated cardiomyopathy was investigated under normal conditions and after TNF-α or TGF-β stimulation.